Poolbeg Pharma IPO and funds raised provide strong platform to begin rapid growth plan
A pharmaceutical company has announced its admission to trading on the London Stock Exchange (IPO) on Monday following a £50m oversubscribed fundraising raised by investor investors in the past few years. Following the announcement, it is expected to become the first privately-owned company to sell shares in London.
Source: directorstalkinterviews.comPublished on 2021-07-19
Related news
- Manitoba well behind Alberta and Quebec in care - home COVID vaccinations
- Moneyhub partners with Envizage to automate planning
- The future of farming will have a platform approach
- Economic Growth , Fossil - Fuel Use , and Air Quality Linked
- Open Orphan announce Poolbeg Pharma to seek admission to AIM London Stock Exchange
- Reasons Why Children Miss Vaccinations in Western Kenya ; A Step in a Five - Point Plan to Improve Routine Immunization
- Sharjah Census : Officials to visit all buildings , facilities to collect data from families , individuals
- First phase of Sharjah Census 2022 begins on Thursday
- Gov unveils Australia first - ever data strategy
- Sharjah Census : Officials To Visit All Buildings , Facilities ...
- UAE : Officials to start visiting homes for biggest Sharjah Census from October 20
- State Comptroller DiNapoli Releases Municipal Audits
- Roundup : Singapore General Hospital to deploy AI - powered PPE checking tool and more briefs
- Resolving The Ship Backlog Puzzle In The Suez Canal : Predicting Ship Transits In Capacity - Constrained Areas
- Investegate |Poolbeg Pharma PLC Announcements | Poolbeg Pharma PLC : Admission to AIM